Global Natural Killer Cell Therapy Market Insights and Forecast to 2031

Report ID: 1241437 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 NK Cell Therapies
        1.2.3 NK Cell Directed Antibodies
    1.3 Market by Application
        1.3.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Gastrointestinal Diseases
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Natural Killer Cell Therapy Market Perspective (2017-2028)
    2.2 Natural Killer Cell Therapy Growth Trends by Region
        2.2.1 Natural Killer Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Natural Killer Cell Therapy Market Dynamics
        2.3.1 Natural Killer Cell Therapy Industry Trends
        2.3.2 Natural Killer Cell Therapy Market Drivers
        2.3.3 Natural Killer Cell Therapy Market Challenges
        2.3.4 Natural Killer Cell Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Natural Killer Cell Therapy Players by Revenue
        3.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2017-2022)
        3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Natural Killer Cell Therapy Revenue
    3.4 Global Natural Killer Cell Therapy Market Concentration Ratio
        3.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2021
    3.5 Natural Killer Cell Therapy Key Players Head office and Area Served
    3.6 Key Players Natural Killer Cell Therapy Product Solution and Service
    3.7 Date of Enter into Natural Killer Cell Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cell Therapy Breakdown Data by Type
    4.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Natural Killer Cell Therapy Breakdown Data by Application
    5.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Natural Killer Cell Therapy Market Size (2017-2028)
    6.2 North America Natural Killer Cell Therapy Market Size by Type
        6.2.1 North America Natural Killer Cell Therapy Market Size by Type (2017-2022)
        6.2.2 North America Natural Killer Cell Therapy Market Size by Type (2023-2028)
        6.2.3 North America Natural Killer Cell Therapy Market Share by Type (2017-2028)
    6.3 North America Natural Killer Cell Therapy Market Size by Application
        6.3.1 North America Natural Killer Cell Therapy Market Size by Application (2017-2022)
        6.3.2 North America Natural Killer Cell Therapy Market Size by Application (2023-2028)
        6.3.3 North America Natural Killer Cell Therapy Market Share by Application (2017-2028)
    6.4 North America Natural Killer Cell Therapy Market Size by Country
        6.4.1 North America Natural Killer Cell Therapy Market Size by Country (2017-2022)
        6.4.2 North America Natural Killer Cell Therapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Natural Killer Cell Therapy Market Size (2017-2028)
    7.2 Europe Natural Killer Cell Therapy Market Size by Type
        7.2.1 Europe Natural Killer Cell Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Natural Killer Cell Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Natural Killer Cell Therapy Market Share by Type (2017-2028)
    7.3 Europe Natural Killer Cell Therapy Market Size by Application
        7.3.1 Europe Natural Killer Cell Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Natural Killer Cell Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Natural Killer Cell Therapy Market Share by Application (2017-2028)
    7.4 Europe Natural Killer Cell Therapy Market Size by Country
        7.4.1 Europe Natural Killer Cell Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Natural Killer Cell Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Natural Killer Cell Therapy Market Size by Type
        8.2.1 Asia-Pacific Natural Killer Cell Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Natural Killer Cell Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Natural Killer Cell Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Application
        8.3.1 Asia-Pacific Natural Killer Cell Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Natural Killer Cell Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Natural Killer Cell Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Region
        8.4.1 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Natural Killer Cell Therapy Market Size (2017-2028)
    9.2 Latin America Natural Killer Cell Therapy Market Size by Type
        9.2.1 Latin America Natural Killer Cell Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Natural Killer Cell Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Natural Killer Cell Therapy Market Share by Type (2017-2028)
    9.3 Latin America Natural Killer Cell Therapy Market Size by Application
        9.3.1 Latin America Natural Killer Cell Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Natural Killer Cell Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Natural Killer Cell Therapy Market Share by Application (2017-2028)
    9.4 Latin America Natural Killer Cell Therapy Market Size by Country
        9.4.1 Latin America Natural Killer Cell Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Natural Killer Cell Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type
        10.2.1 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Natural Killer Cell Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Application
        10.3.1 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Natural Killer Cell Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country
        10.4.1 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Nektar Therapeutics
        11.1.1 Nektar Therapeutics Company Details
        11.1.2 Nektar Therapeutics Business Overview
        11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
        11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.1.5 Nektar Therapeutics Recent Developments
    11.2 Innate Pharma SA
        11.2.1 Innate Pharma SA Company Details
        11.2.2 Innate Pharma SA Business Overview
        11.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
        11.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.2.5 Innate Pharma SA Recent Developments
    11.3 Affimed
        11.3.1 Affimed Company Details
        11.3.2 Affimed Business Overview
        11.3.3 Affimed Natural Killer Cell Therapy Introduction
        11.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.3.5 Affimed Recent Developments
    11.4 Chipscreen Biosciences
        11.4.1 Chipscreen Biosciences Company Details
        11.4.2 Chipscreen Biosciences Business Overview
        11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction
        11.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.4.5 Chipscreen Biosciences Recent Developments
    11.5 Glycostem Therapeutics
        11.5.1 Glycostem Therapeutics Company Details
        11.5.2 Glycostem Therapeutics Business Overview
        11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
        11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.5.5 Glycostem Therapeutics Recent Developments
    11.6 Fate Therapeutics
        11.6.1 Fate Therapeutics Company Details
        11.6.2 Fate Therapeutics Business Overview
        11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
        11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.6.5 Fate Therapeutics Recent Developments
    11.7 Dragonfly Therapeutics
        11.7.1 Dragonfly Therapeutics Company Details
        11.7.2 Dragonfly Therapeutics Business Overview
        11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
        11.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.7.5 Dragonfly Therapeutics Recent Developments
    11.8 Kiadis Pharma
        11.8.1 Kiadis Pharma Company Details
        11.8.2 Kiadis Pharma Business Overview
        11.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction
        11.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.8.5 Kiadis Pharma Recent Developments
    11.9 Nkarta Therapeutics
        11.9.1 Nkarta Therapeutics Company Details
        11.9.2 Nkarta Therapeutics Business Overview
        11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
        11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.9.5 Nkarta Therapeutics Recent Developments
    11.10 NantKwest
        11.10.1 NantKwest Company Details
        11.10.2 NantKwest Business Overview
        11.10.3 NantKwest Natural Killer Cell Therapy Introduction
        11.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2017-2022)
        11.10.5 NantKwest Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of NK Cell Therapies
    Table 3. Key Players of NK Cell Directed Antibodies
    Table 4. Global Natural Killer Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Natural Killer Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Natural Killer Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Natural Killer Cell Therapy Market Share by Region (2017-2022)
    Table 8. Global Natural Killer Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Natural Killer Cell Therapy Market Share by Region (2023-2028)
    Table 10. Natural Killer Cell Therapy Market Trends
    Table 11. Natural Killer Cell Therapy Market Drivers
    Table 12. Natural Killer Cell Therapy Market Challenges
    Table 13. Natural Killer Cell Therapy Market Restraints
    Table 14. Global Natural Killer Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Natural Killer Cell Therapy Revenue Share by Players (2017-2022)
    Table 16. Global Top Natural Killer Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2021)
    Table 17. Ranking of Global Top Natural Killer Cell Therapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Natural Killer Cell Therapy Product Solution and Service
    Table 21. Date of Enter into Natural Killer Cell Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Natural Killer Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Natural Killer Cell Therapy Revenue Market Share by Type (2017-2022)
    Table 25. Global Natural Killer Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Natural Killer Cell Therapy Revenue Market Share by Type (2023-2028)
    Table 27. Global Natural Killer Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Natural Killer Cell Therapy Revenue Share by Application (2017-2022)
    Table 29. Global Natural Killer Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Natural Killer Cell Therapy Revenue Share by Application (2023-2028)
    Table 31. North America Natural Killer Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Natural Killer Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Natural Killer Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Natural Killer Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Natural Killer Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Natural Killer Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Natural Killer Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Natural Killer Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Natural Killer Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Natural Killer Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Natural Killer Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Natural Killer Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Natural Killer Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Natural Killer Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Natural Killer Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Natural Killer Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Natural Killer Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Natural Killer Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Natural Killer Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Natural Killer Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Natural Killer Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Natural Killer Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Natural Killer Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Natural Killer Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Natural Killer Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Natural Killer Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Natural Killer Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Natural Killer Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Natural Killer Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Natural Killer Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Nektar Therapeutics Company Details
    Table 62. Nektar Therapeutics Business Overview
    Table 63. Nektar Therapeutics Natural Killer Cell Therapy Product
    Table 64. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 65. Nektar Therapeutics Recent Developments
    Table 66. Innate Pharma SA Company Details
    Table 67. Innate Pharma SA Business Overview
    Table 68. Innate Pharma SA Natural Killer Cell Therapy Product
    Table 69. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 70. Innate Pharma SA Recent Developments
    Table 71. Affimed Company Details
    Table 72. Affimed Business Overview
    Table 73. Affimed Natural Killer Cell Therapy Product
    Table 74. Affimed Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 75. Affimed Recent Developments
    Table 76. Chipscreen Biosciences Company Details
    Table 77. Chipscreen Biosciences Business Overview
    Table 78. Chipscreen Biosciences Natural Killer Cell Therapy Product
    Table 79. Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 80. Chipscreen Biosciences Recent Developments
    Table 81. Glycostem Therapeutics Company Details
    Table 82. Glycostem Therapeutics Business Overview
    Table 83. Glycostem Therapeutics Natural Killer Cell Therapy Product
    Table 84. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 85. Glycostem Therapeutics Recent Developments
    Table 86. Fate Therapeutics Company Details
    Table 87. Fate Therapeutics Business Overview
    Table 88. Fate Therapeutics Natural Killer Cell Therapy Product
    Table 89. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 90. Fate Therapeutics Recent Developments
    Table 91. Dragonfly Therapeutics Company Details
    Table 92. Dragonfly Therapeutics Business Overview
    Table 93. Dragonfly Therapeutics Natural Killer Cell Therapy Product
    Table 94. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 95. Dragonfly Therapeutics Recent Developments
    Table 96. Kiadis Pharma Company Details
    Table 97. Kiadis Pharma Business Overview
    Table 98. Kiadis Pharma Natural Killer Cell Therapy Product
    Table 99. Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 100. Kiadis Pharma Recent Developments
    Table 101. Nkarta Therapeutics Company Details
    Table 102. Nkarta Therapeutics Business Overview
    Table 103. Nkarta Therapeutics Natural Killer Cell Therapy Product
    Table 104. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 105. Nkarta Therapeutics Recent Developments
    Table 106. NantKwest Company Details
    Table 107. NantKwest Business Overview
    Table 108. NantKwest Natural Killer Cell Therapy Product
    Table 109. NantKwest Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
    Table 110. NantKwest Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Natural Killer Cell Therapy Market Share by Type: 2021 VS 2028
    Figure 2. NK Cell Therapies Features
    Figure 3. NK Cell Directed Antibodies Features
    Figure 4. Global Natural Killer Cell Therapy Market Share by Application: 2021 VS 2028
    Figure 5. Cancer Case Studies
    Figure 6. Gastrointestinal Diseases Case Studies
    Figure 7. Others Case Studies
    Figure 8. Natural Killer Cell Therapy Report Years Considered
    Figure 9. Global Natural Killer Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Natural Killer Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Natural Killer Cell Therapy Market Share by Region: 2021 VS 2028
    Figure 12. Global Natural Killer Cell Therapy Market Share by Players in 2021
    Figure 13. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2021
    Figure 15. North America Natural Killer Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Natural Killer Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 17. North America Natural Killer Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 18. North America Natural Killer Cell Therapy Market Size Share by Country (2017-2028)
    Figure 19. United States Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Natural Killer Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Natural Killer Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Natural Killer Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Natural Killer Cell Therapy Market Size Share by Country (2017-2028)
    Figure 25. Germany Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Natural Killer Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Natural Killer Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Natural Killer Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Natural Killer Cell Therapy Market Size Share by Region (2017-2028)
    Figure 35. China Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Natural Killer Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Natural Killer Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Natural Killer Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Natural Killer Cell Therapy Market Size Share by Country (2017-2028)
    Figure 45. Mexico Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Natural Killer Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Natural Killer Cell Therapy Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Natural Killer Cell Therapy Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Natural Killer Cell Therapy Market Size Share by Country (2017-2028)
    Figure 51. Turkey Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Natural Killer Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 55. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 56. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 57. Chipscreen Biosciences Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 58. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 59. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 60. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 61. Kiadis Pharma Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 62. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 63. NantKwest Revenue Growth Rate in Natural Killer Cell Therapy Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Frequently Asked Questions
Natural Killer Cell Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Natural Killer Cell Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Natural Killer Cell Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sodium Sulphide

Sodium Sulphide market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Allergen Blocker

Allergen Blocker market is segmented by Type and by Sale Channel. Players, stakeholders, and othe ... Read More